Hadassah Medical Organization (2016) Explorative Trial to Investigate the Migration Ability of Mesenchymal Bone Marrow Stem Cells (MSC) in the Central Nervous System (CNS) Following Their Intrathecal Administration in Severe Cases of Multiple Sclerosis (MS). 1872 NCT0078.

has been cited by the following article:

• TITLE: Treatment of Multiple Sclerosis

  AUTHORS: M. Nadeem, O. Mufti, I. Ahsan, R. Naheed, S. M. Faheem

  KEYWORDS: Immune Sequestration, Multiple Sclerosis, Non-Specific Immune Modulation, Lymphocyte-Targeted Therapy

  JOURNAL NAME: Neuroscience and Medicine, Vol.7 No.2, June 22, 2016

  ABSTRACT: Background: A new method of immune-based therapies has been made and applied on multiple sclerosis patients in last decades. Some of these treatments have a high efficacy and reasonable side effects. In slowing disease progression, present treatments have significant limitations, but often associated with significant adverse effects of immunosuppression, with having a bit low capability to counter the disability. Methods: This is a review meta-analysis of treatment of multiple sclerosis. Results: Thus a valuable aim for multiple sclerosis clinical research is to introduce more effective therapies. Conclusion: It is absolutely necessary to increase the individualized therapy planes development in respect to make better planes to disease-modifying treatments.